Managing Your Due Diligence Process Throughout the Life Cycle of a Life Sciences Company
December 4, 2007
Ensuring top value of a product throughout the lifecycle process involves managing issues related to evaluating a potential product; Identifying the best people for a project, recognizing key value factors of a product, and managing the size, flow and duration of a project. This panel will specifically address:
- How does your evaluation of a project differ in the big Pharma setting vs. a more entrepreneurial setting?
- What factors do you consider in determining whether their will be life after the patent on the active
- How have considerations changed in doing research (basic and developmental) in the last 10 years?
- What are some sources for evaluating the likelihood of success of a project?
Panelists include: Kim Graham, Former Director, Cambridge Antibody Technology Inc.; Ed LeFevre, Partner, Foley; Roberto Rosenkranz, Ph.D., Chairman and CEO, ROXRO PHARMA; and L. James Strand, M.D., General Partner, Managing Director, Institutional Venture Partners (IVP).
Related Insights
June 23, 2025
Events
Third Annual Transaction Solutions Symposium
Foley & Lardner is sponsoring the Third Annual Transaction Solutions Symposium — a premier conference focused on de-risking strategies that enhance deal execution and business outcomes. Rishi Sodhi will be speaking as part of the Tax Liability Insurance: Current Trends, Controversies and Claims panel.
June 5, 2025
Health Care Law Today
GLP-1 Compounded Medications Targeted by Connecticut Attorney General
On May 21, 2025, the Connecticut Office of the Attorney General released a statement and sent letters to Connecticut weight loss clinics, med spas, medical practices and other businesses regarding allegedly or potentially unfair and deceptive conduct relating to compounded GLP-1 medications.
June 4, 2025
Energy Current
Nuclear’s Comeback: What Renewables Professionals Should Know
The clean energy transition isn’t a zero-sum game – it’s a team effort. And one player is stepping back into the spotlight with renewed…